Tranexamic Acid in Treatment of Facial Erythema

• Status: Completed
• Trial end date: 2022-08-30
• Target enrollment: 0
• Participant gender: Female

Summary

Our aim is to evaluate the efficacy of 10% topical tranexamic acid with microneedling in treatment of facial erythema

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Azhar University
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

Female Patients Patients with persistent facial erythema and telangiectasia. Co-operative patient and patients willing for the procedure

Exclusion Criteria:

Patients with active infection at the local site or recurrent herpes. Patients with history of bleeding disorders or anticoagulant medications Patients with history of scar and keloid formation. Patients with unrealistic expectations. Pregnant or lactating women